Replacement of Lamivudine by Telbivudine to Improve Renal Function
Status:
Completed
Trial end date:
2017-01-31
Target enrollment:
Participant gender:
Summary
Nephrotoxicity is one of the adverse effects of lamivudine and dosage of lamivudine has to be
reduced if patients' renal function is insufficiency. Telbivudine may improve glomerular
filtration rate. This study is to see whether renal function is improved when Lamivudine is
replaced by telbivudine in liver transplantation patients.